GGrantIndex
Sort

10,829 grants matching car t

Development and Validation of a Patient-Reported Measure Assessing Chimeric Antigen Receptor (CAR) T-Cell Therapy-Related Side Effects

$67,000
Anna Barata · Massachusetts General Hospital · R03 · FY2022 · CA

Relationships Between Urban Population Densities and the Carbon Efficiency of Public Transit and Private Vehicles

$66,999
Bumsoo Lee · University Of Illinois At Urbana-Champaign · · FY2017 · SBE

Novel TCR transgenic mice to study tumor neoantigen-specific T cell responses

$66,992
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R03 · FY2025 · CA

Novel TCR transgenic mice to study tumor neoantigen-specific T cell responses

$66,992
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R03 · FY2024 · CA

Allograft rejection and salvage therapy with chimeric antigen receptor T-regulatory cells in murine hindlimb transplant

$66,790
Nicole Conkling · University Of California, San Francisco · F32 · FY2018 · AI

Junction Adhesion Molecule CAR and the Immune System

$66,450
University Of Nebraska Medical Center · R01 · FY2003 · AI

CRII: RI: Deep neural network pruning for fast and reliable visual detection in self-driving vehicles

$66,414
Qing Tian · University Of Alabama At Birmingham · · FY2024 · CSE

THIS PROPOSAL FOCUSES ON EXTENDING OUR UNDERSTANDING OF THE FORMATION OF CARBONATE MINERALS ON MARS BY (1) PERFORMING NEW STUDIES TO CHARACTERIZE CAR

$66,364
Arizona State University · · FY2014 · National Aeronautics and Space Administration

Translational Research Core - Engagement and Behavior Change

$66,113
Ralph J Diclemente · Emory University · P30 · FY2020 · DK

Translational Research Core - Engagement and Behavior Change

$66,113
Ralph J Diclemente · Emory University · P30 · FY2019 · DK

Morbidity Following Breast Cancer Treatment:a Prospective Study

$66,000
Ellen Levy · Clinical Center · Z01 · FY2007 · CL

Health Evaluation of the Neighborhoods Law Phase 2 (HENL2)

$66,000
Roshanak Mehdipanah · University Of Michigan At Ann Arbor · R03 · FY2019 · MD

A Comprehensive analysis and the impact of promemory gene incorporation on CAR T cell memory differentiation in the context of solid tumors

$65,994
Steven James Reed · Seattle Children'S Hospital · F32 · FY2021 · CA

Characterizing and Targeting the Hypoxic T Cell Surfaceome to Promote Immune Function in Cancer

$65,994
James Robert Byrnes · University Of California, San Francisco · F32 · FY2021 · CA

Bioengineering programmable and drug-controllable synthetic receptors fortunable CAR-T cell behaviors

$65,994
Nicholas Antonios Kalogriopoulos · Stanford University · F32 · FY2021 · CA

Higher-Order Visual Decision Making: Networks and Mechanisms

$65,590
Andrew S Kayser · Ernest Gallo Clinic And Research Center · R01 · FY2014 · EY

Membrane Transporters: Critical Determinants For Aids Antiviral Drugs

$65,366
David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Evaluation of a structure-function model for auditory consequences of impact acceleration brain injury and protection via the olivocochlear system

$65,336
Kali Burke · Johns Hopkins University · F32 · FY2023 · DC

SGER: Optimal Strategies for Moving Droplets in Digital Microfluidic Systems

$64,908
Karl F Bohringer · University Of Washington · · FY2003 · CSE

Developing personalized immunosuppression for older kidney transplant recipients

$64,902
Mara A. McAdams Demarco · Johns Hopkins University · R01 · FY2022 · DK

REGULATION OF RENAL CALCIUM TRANSPORT BY CALCIUM

$64,778
University Of Louisville · R01 · FY2000 · DK

Hematologic Malignancies and Cellular Therapies Research Program

$64,644
Michael Barry Kastan · Duke University · P30 · FY2015 · CA

Characterizing and Targeting the Hypoxic T Cell Surfaceome to Promote Immune Function in Cancer

$64,554
James Robert Byrnes · University Of California, San Francisco · F32 · FY2020 · CA

Preventing Disability from MSK Pain in Northern Tanzania

$64,305
Adam Goode · Duke University · R03 · FY2021 · AG

Hematologic Malignancies

$64,084
Stephen J Forma · Beckman Research Institute/City Of Hope · P30 · FY2020 · CA